111 related articles for article (PubMed ID: 20709036)
1. Relationship between methamphetamine-induced behavioral activation and hyperthermia.
Phelps G; Speaker HA; Sabol KE
Brain Res; 2010 Oct; 1357():41-52. PubMed ID: 20709036
[TBL] [Abstract][Full Text] [Related]
2. The effects of the β1 antagonist, metoprolol, on methamphetamine-induced changes in core temperature in the rat.
Harrell R; Speaker HA; Mitchell SL; Sabol KE
Neurosci Lett; 2015 Nov; 609():81-6. PubMed ID: 26388403
[TBL] [Abstract][Full Text] [Related]
3. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Hagiwara H; Iyo M; Hashimoto K
Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
[TBL] [Abstract][Full Text] [Related]
4. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys.
Yuan J; Hatzidimitriou G; Suthar P; Mueller M; McCann U; Ricaurte G
J Pharmacol Exp Ther; 2006 Mar; 316(3):1210-8. PubMed ID: 16293712
[TBL] [Abstract][Full Text] [Related]
5. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
[TBL] [Abstract][Full Text] [Related]
6. The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry.
Sabol KE; Richards JB; Yung K
J Pharmacol Exp Ther; 2000 Sep; 294(3):850-63. PubMed ID: 10945833
[TBL] [Abstract][Full Text] [Related]
7. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
8. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker.
Sabol KE; Yancey DM; Speaker HA; Mitchell SL
Psychopharmacology (Berl); 2013 Aug; 228(4):551-61. PubMed ID: 23732837
[TBL] [Abstract][Full Text] [Related]
11. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
12. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
13. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
[TBL] [Abstract][Full Text] [Related]
14. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
15. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
16. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
17. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
18. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
20. Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice.
Li JX; Han R; Deng YP; Chen SQ; Liang JH
Behav Brain Res; 2005 Jun; 161(1):125-32. PubMed ID: 15904719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
